Skip to main content

Table 3 Medical treatments at discharge

From: Clinical characteristics, management, and 5-year survival compared between no standard modifiable risk factor (SMuRFless) and ≥ 1 SMuRF ACS cases: an analysis of 15,051 cases from Pakistan

Variables

Total

SMuRFless

≥ 1 SMuRF

p-value

N = 15051

N = 2267

N = 12784

n (%)

n (%)

n (%)

Beta-blockers

12561 (85.4%)

1862 (84.1%)

10699 (85.6%)

0.06

Statins

13387 (88.9%)

1957 (86.3%)

11430 (89.4%)

< 0.01

Aspirin

13402 (89.0%)

1964 (86.6%)

11438 (89.7%)

< 0.01

ACE-I/ARB

10447 (69.4%)

1540 (68.1%)

8907 (69.8%)

0.1

  1. ACE-I/ARB = Angiotensin converting enzymes/Angiotensin Receptor Blocking agent
  2. SMuRF = Standard Modifiable Risk Factor
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us